News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,192 Results
Type
Article (40426)
Company Profile (261)
Press Release (671496)
Multimedia
Podcasts (70)
Webinars (17)
Section
Business (204476)
Career Advice (2016)
Deals (35477)
Drug Delivery (99)
Drug Development (81239)
Employer Resources (173)
FDA (16313)
Job Trends (14915)
News (345914)
Policy (32684)
Tag
Academia (2559)
Accelerated approval (15)
Adcomms (24)
Allergies (113)
Alliances (49575)
ALS (133)
Alzheimer's disease (1549)
Antibody-drug conjugate (ADC) (204)
Approvals (16403)
Artificial intelligence (382)
Autoimmune disease (63)
Automation (26)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (146)
Biotechnology (175)
Bladder cancer (125)
Brain cancer (44)
Breast cancer (474)
Cancer (3682)
Cardiovascular disease (293)
Career advice (1693)
Career pathing (33)
CAR-T (220)
CDC (42)
Cell therapy (591)
Cervical cancer (31)
Clinical research (67998)
Collaboration (1267)
Company closure (4)
Compensation (909)
Complete response letters (42)
COVID-19 (2673)
CRISPR (70)
C-suite (541)
Cystic fibrosis (125)
Data (4349)
Decentralized trials (2)
Denatured (22)
Depression (93)
Diabetes (416)
Diagnostics (6527)
Digital health (32)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (177)
Drug pricing (154)
Drug shortages (28)
Duchenne muscular dystrophy (190)
Earnings (88674)
Editorial (45)
Employer branding (21)
Employer resources (150)
Events (115154)
Executive appointments (919)
FDA (18666)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (13)
Funding (1155)
Gene editing (155)
Generative AI (28)
Gene therapy (469)
GLP-1 (858)
Government (4597)
Grass and pollen (5)
Guidances (337)
Healthcare (18854)
HIV (42)
Huntington's disease (34)
IgA nephropathy (58)
Immunology and inflammation (199)
Immuno-oncology (15)
Indications (52)
Infectious disease (2887)
Inflammatory bowel disease (169)
Inflation Reduction Act (12)
Influenza (87)
Intellectual property (181)
Interviews (314)
IPO (16607)
IRA (48)
Job creations (3639)
Job search strategy (1426)
Kidney cancer (14)
Labor market (69)
Layoffs (531)
Leadership (24)
Legal (7937)
Liver cancer (84)
Longevity (11)
Lung cancer (533)
Lymphoma (256)
Machine learning (28)
Management (59)
Manufacturing (565)
MASH (129)
Medical device (13596)
Medtech (13617)
Mergers & acquisitions (19727)
Metabolic disorders (1016)
Multiple sclerosis (131)
NASH (16)
Neurodegenerative disease (192)
Neuropsychiatric disorders (47)
Neuroscience (2481)
NextGen: Class of 2025 (6516)
Non-profit (4493)
Now hiring (56)
Obesity (475)
Opinion (236)
Ovarian cancer (131)
Pain (147)
Pancreatic cancer (164)
Parkinson's disease (224)
Partnered (27)
Patents (395)
Patient recruitment (297)
Peanut (52)
People (58179)
Pharmaceutical (63)
Pharmacy benefit managers (23)
Phase I (21171)
Phase II (29936)
Phase III (22300)
Pipeline (2638)
Policy (242)
Postmarket research (2564)
Preclinical (9002)
Press Release (64)
Prostate cancer (188)
Psychedelics (42)
Radiopharmaceuticals (256)
Rare diseases (582)
Real estate (5935)
Recruiting (68)
Regulatory (23405)
Reports (51)
Research institute (2349)
Resumes & cover letters (351)
Rett syndrome (15)
RNA editing (11)
RSV (62)
Schizophrenia (121)
Series A (187)
Series B (145)
Service/supplier (11)
Sickle cell disease (72)
Special edition (20)
Spinal muscular atrophy (149)
Sponsored (34)
Startups (3598)
State (2)
Stomach cancer (14)
Supply chain (92)
Tariffs (79)
The Weekly (46)
Vaccines (893)
Venture capital (62)
Weight loss (308)
Women's health (53)
Worklife (17)
Date
Today (121)
Last 7 days (618)
Last 30 days (2313)
Last 365 days (30614)
2025 (24082)
2024 (35218)
2023 (40077)
2022 (51179)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29265)
2010 (27328)
Location
Africa (726)
Alabama (71)
Alaska (7)
Arizona (265)
Arkansas (13)
Asia (38615)
Australia (6307)
California (9038)
Canada (2786)
China (826)
Colorado (380)
Connecticut (387)
Delaware (254)
Europe (83162)
Florida (1352)
Georgia (296)
Hawaii (2)
Idaho (60)
Illinois (705)
India (44)
Indiana (431)
Iowa (17)
Japan (311)
Kansas (117)
Kentucky (33)
Louisiana (16)
Maine (68)
Maryland (1191)
Massachusetts (6621)
Michigan (279)
Minnesota (524)
Mississippi (4)
Missouri (107)
Montana (29)
Nebraska (25)
Nevada (102)
New Hampshire (69)
New Jersey (2492)
New Mexico (28)
New York (2464)
North Carolina (1237)
North Dakota (8)
Northern California (4167)
Ohio (277)
Oklahoma (20)
Oregon (36)
Pennsylvania (1905)
Puerto Rico (18)
Rhode Island (43)
South America (1099)
South Carolina (47)
South Dakota (1)
Southern California (3482)
Tennessee (145)
Texas (1394)
United States (32860)
Utah (269)
Virginia (218)
Washington D.C. (76)
Washington State (758)
West Virginia (4)
Wisconsin (77)
Wyoming (1)
712,192 Results for "viacyte inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
CRISPR/ViaCyte and Genprex Vie for First Diabetes Gene Therapy
Partners CRISPR and ViaCyte (Vertex), and Genprex are pioneers in the quest to develop a gene therapy for Type 1 diabetes.
March 10, 2023
·
3 min read
·
Jia Jie Chen
Press Releases
Apollomics, Inc. Company Operational Continuity Update
October 14, 2025
·
6 min read
Press Releases
PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
October 20, 2025
·
5 min read
Press Releases
Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.
October 20, 2025
·
8 min read
Press Releases
Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit
October 14, 2025
·
2 min read
Press Releases
Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace
October 17, 2025
·
5 min read
Press Releases
NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards
October 20, 2025
·
2 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES ACQUISITION AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
September 11, 2025
·
4 min read
Business
Vertex’s Viacyte Backs Out of CRISPR Diabetes Deal
Vertex still has an ongoing diabetes partnership with CRISPR, which gives it a non-exclusive license to the latter’s platform to develop a potential cure for type 1 diabetes.
January 9, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Praxis Precision Medicines, Inc. Announces Pricing of $525 Million Public Offering
October 17, 2025
·
4 min read
1 of 71,220
Next
